eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Bristol-Myers Squibb Pharmaceutical Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 08/04/2011
PIL Zerit 200 mg Powder for Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to storage instructions
  • Change to information about driving or using machinery
Updated on 04/10/2010 and displayed until 08/04/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 03/06/2010 and displayed until 04/10/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 18/01/2010 and displayed until 03/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 19/07/2007 and displayed until 18/01/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
Updated on 02/06/2005 and displayed until 19/07/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   stavudine